Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use.
Andrew P McGovernMichael FeherNeil MunroSimon de LusignanPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)
AstraZeneca.